Bectumomab
WikiDoc Resources for Bectumomab |
Articles |
---|
Most recent articles on Bectumomab |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Bectumomab at Clinical Trials.gov Clinical Trials on Bectumomab at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Bectumomab
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Bectumomab Discussion groups on Bectumomab Patient Handouts on Bectumomab Directions to Hospitals Treating Bectumomab Risk calculators and risk factors for Bectumomab
|
Healthcare Provider Resources |
Causes & Risk Factors for Bectumomab |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Bectumomab (marketed under the trade name LymphoScan®) is a mouse monoclonal antibody and which it's used to treat non-Hodgkin's lymphoma. It has a radioisotope, technetium (99m TC) which it's added.